Oligonucleotide Synthesis Market Size, Share, Scope And Forecast To 2025

The Report Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By End Use, By Product (Column-based, Array-based, Services), By Application (PCR Primer, FISH), And Segment Forecasts, 2018 – 2025

The global Oligonucleotide Synthesis Market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Continuous rise in usage of oligonucleotide synthesis across various aspects of human health management, from molecular diagnostics to therapeutics, is spurring revenue growth.

The recent success of oligonucleotide-based drugs in medicine due to increase in number of FDA-approved products is anticipated to boost revenue generation in this market. As of September 2017, there are six approved oligonucleotide therapeutic products.

A substantial number of oligos are being investigated for their usage in targeting various infectious diseases. For instance, dsDNA thioaptamers are reported to target the ribonuclease H (RNase H) domain of HIV-RT and are demonstrated to inhibit HIV-RT when used in vitro.

In addition, demand for cancer-related thioapatmers that can detect presence as well as target tumor growth factors, such as TGF-β, is on a continuous rise. This, in turn, has led to increase in investments for exploring the significance of custom oligonucleotide synthesis in cancer research.

Access Research Report of Oligonucleotide Synthesis Market @  www.grandviewresearch.com/industry-analysis/oligonucleotide-synthesis-market

Further key findings from the report suggest:

·       Growing usage of ready as well as custom oligos in genomic research is expected to drive the market

·       Column-based oligos have a higher per nucleotide base price compared to array-based oligos. As a result, column-based oligos accounted for the largest revenue share by product type in 2017

·       North America dominated the global market in 2017 as a result of large investments in genetic research and effective regulatory policies that encourage gene-based research activities in the region

·       Asian countries are expected to emerge as a key source of lucrative revenue generation during the forecast period. This is primarily due to growing awareness as well as popularity of genetic medicine among the population

·       The market is highly fragmented, with the presence of several major and emerging players offering DNAs, RNAs, and other oligos. Market competition is anticipated to increase with growing number of new entrants offering customized services

·       Some of the key companies in the market are BioAutomation; Integrated DNA Technologies, Inc.; LGC Biosearch Technologies; Agilent Technologies; GE Healthcare Dharmacon Inc.; and Gene Scripts.

Grand View Research has segmented the global oligonucleotide synthesis market on the basis of product, application, end use, and region:

Oligonucleotide Synthesis Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Oligonucleotides

o    Oligonucleotides, By Product Type

o  Column-based Oligos

o  Array-based Oligos

o    Oligonucleotides, By Nucleic Acid Type

o  DNA

o  RNA

·         Equipment

·         Reagents

·         Services

o    Oligo Synthesis

o  25 nmol

o  50 nmol

o  200 nmol

o  1000 nmol

o  10,000 nmol

o    Purification

o    Modification

Oligonucleotide Synthesis Application Outlook (Revenue, USD Million, 2014 - 2025)

·         PCR Primers

·         PCR Assays and Panels

·         Sequencing

·         DNA Microarrays

·         Fluorescence In Situ Hybridization (FISH)

·         Antisense Oligonucleotides

·         Other Applications

Oligonucleotide Synthesis End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Academic Research Institutes

·         Diagnostic Laboratories

·         Pharmaceutical & Biotechnology Companies

Oligonucleotide Synthesis Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    U.K.

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

·         Middle East and Africa (MEA)

o    South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Surgical Retractors Market Registering At A CAGR Of 3.2% For The Forecast Period From 2018 To 2025

The Report Surgical Retractors Market Analysis Report By Type (Hand-held, Self-retaining), By Product, By Application, By End Use (Hospitals, Ambulatory Surgical Centers), And Segment Forecasts, 2018 – 2025

The global Surgical Retractors Market size is expected to reach USD 1.81 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.2% CAGR over the forecast period. The market is primarily driven by unprecedented upsurge in surgical volume over the past few years. According to data published by WHO, the global surgical volume was estimated at 312.9 million in 2012 from 226.4 million in 2004. The statistics also showed that the mean global surgical rate is approximately 4,469 surgeries per 100,000 population per year. These numbers exemplify the widening scope of surgery and adoption of retractors.

Increase in number of cesarean surgeries has fueled demand for C-section retractors. As per the American Medical Association, adoption rate of cesarean surgeries is around 19.0% globally. Technological developments, such as automation in surgical instruments, are improving minimally invasive surgeries, thus creating high growth potential for the market. For instance, advent of atraumatic laparoscopic retractors and 3D retractors has ensured greater safety during surgeries and reduced post-operative complications.

Access Research Report of Surgical Retractors Market @ www.grandviewresearch.com/industry-analysis/surgical-retractors-market

Further key findings from the report suggest:

·       By type, hand-held retractors accounted for the largest share in 2017 as a result of advantages such as low cost of product handling, storage, and maintenance. Self-retaining retractors are predicted to exhibit lucrative growth owing to greater convenience associated with them

·       On the basis of product, orthopedic retractors held a considerable share in 2017 owing to increasing incidence of orthopedic disorders in bariatric and geriatric patients

·       Obstetrics and gynecology dominated the market based on application owing to upsurge in number of C-section surgeries and gynecological preventive examinations globally

·       In 2017, North America held a substantial market share owing to growing prevalence of chronic diseases and presence of highly advanced medical infrastructure. Adoption of technologically advanced products is also presenting high growth prospects

·       The market in Asia Pacific is anticipated to witness significant growth owing to improving healthcare systems, rising healthcare expenditure, and growing awareness

·       Key companies include Teleflex, Johnson & Johnson, B.Braun, Medtronic, Thompson Surgical, and Becton, Dickinson and Company

·       The market is highly competitive with key participants consistently deploying strategies such as mergers and acquisitions to gain competitive advantage. For instance, in April 2017, Teleflex acquired Pyng Medical to gain a leadership position and expand its product portfolio.

Grand View Research has segmented the global surgical retractors market on the basis of type, product, application, end use, and region:

Surgical Retractors Type Outlook (Revenue, USD Million, 2014 - 2025)

·         Hand-held

·         Self-retaining

Surgical Retractors Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Abdominal

·         Finger

·         Nerve

·         Orthopedic

·         Rectal

·         Thoracic

·         Ribbon

·         Others

Surgical Retractors Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Neurosurgery

·         Wound Closure

·         Reconstructive Surgery

·         Cardiovascular

·         Orthopedic

·         Obstetrics & Gynecology

·         Others

Surgical Retractors End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals

·         Ambulatory Surgical Centers

·         Others

Surgical Retractors Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    U.K.

o    Germany

·         Asia Pacific

o    Japan

o    China

o    India

·         Latin America

o    Brazil

o    Mexico

·         Middle East & Africa

o    South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

U.S. Sterilization Services Market Predicted to Cross USD 2.72 Billion by 2025

The U.S. sterilization services market size is expected to reach USD 2.72 billion by 2025, according to a new report by Grand View Research, Inc., registering a 5.1% CAGR during the forecast period. Supportive government investments in the healthcare industry, increasing R&D activities, and rising volume of drug launches are key factors impacting market growth.

The U.S. government has been keen on curbing healthcare costs and this is anticipated to encourage the FDA to speed up approval procedures for generic pharmaceuticals. Faster approvals drive the need for newer sterility testing methods, compelling innovative market participants to spend more on such solutions, thereby propelling the market. With increasing demand for drugs, companies are launching newer drugs with different routes of administration, dosage, or for a new indication. These launches require thorough sterility testing and this is anticipated to drive market growth.

By end use, the market is divided into hospitals, pharmaceuticals, medical device companies, clinical laboratories/research centers, and others, which includes food and beverage companies. Hospitals dominated the overall sterilization services market in 2016 and the segment is expected to retain its top position throughout the forecast period. Increasing incidence of hospital-acquired infections, growing number of surgical procedures, and constantly rising patient pool are prime factors driving this segment.

Currently, the U.S. sterilization services industry is consolidated in nature with only a few top companies capturing the major share. Some of the leading players are STERIS Corporation; Getinge Group; and Advanced Sterilization Products Services, Inc. Other prominent companies include 3M, Belimed, Cantel Medical, MATACHANA GROUP, and Sterigenics International LLC. In September 2016, Cantel announced the acquisition of Vantage Endoscopy’s endoscopy assets. This expansion of direct sales and acquisition of assets of its Canadian distributor is expected to strengthen the company’s position in the infection prevention market.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/us-sterilization-services-market

Further key findings from the report suggest:

·       The U.S. sterilization services market was valued at USD 1.83 billion in 2017 and is expected to grow lucratively over the forecast period

·       In terms of revenue, the offsite delivery mode segment is anticipated to exhibit a strong growth rate through 2025

·       The contract services market was valued at USD 1.27 billion in 2017 and is anticipated to register the fastest CAGR over the forecast period.                                 

Grand View Research has segmented the U.S. sterilization services market on the basis of technique, type, delivery mode, and end use:

U.S. Sterilization Services Technique Outlook (Revenue, USD Million, 2012 - 2025)

·         Steam

·         EtO

·         E-beam radiation

·         Gamma radiation

·         Others

U.S. Sterilization Services Type Outlook (Revenue, USD Million, 2012 - 2025)

·         Contract services

·         Validation services

U.S. Sterilization Services Delivery Mode Outlook (Revenue, USD Million, 2012 - 2025)

·         Onsite

·         Offsite

U.S. Sterilization Services End-use Outlook (Revenue, USD Million, 2012 - 2025)

·         Hospitals

·         Pharmaceutical companies

·         Medical device companies

·         Clinical laboratories

·         Others

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com